Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial

BACKGROUND: HX575 is a human recombinant epoetin alfa that was approved for use in Europe in 2007 under the European Medicines Agency biosimilar approval pathway. Therefore, in order to demonstrate the bioequivalence of HX575 to an existing epoetin alfa, the pharmacokinetic and pharmacodynamic respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sörgel, Fritz, Thyroff-Friesinger, Ursula, Vetter, Andrea, Vens-Cappell, Bernhard, Kinzig, Martina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695417/
https://www.ncbi.nlm.nih.gov/pubmed/19463151
http://dx.doi.org/10.1186/1472-6904-9-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695417/
https://www.ncbi.nlm.nih.gov/pubmed/19463151
http://dx.doi.org/10.1186/1472-6904-9-10

Ejemplares similares